Amneal Launches Ready-To-Use Pemetrexed And OTC Naloxone

More 505(b)(2) Product Launches Are Expected This Year

Amneal launched two highly anticipated products, a ready-to-use pemetrexed injectable Pemrydi and over-the-counter naloxone spray, strengthening the firm’s focus on injectables and inhalation.

Amneal logo
• Source: Shutterstock

Ready, steady, go. Amneal marked its first 505(b)(2) product launch of the year as the firm’s first and only ready-to-use Pemrydi RTU (pemetrexed) hit the US market.

[Sidebar#GB153352]

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin